A detailed history of Carl P. Sherr & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Carl P. Sherr & Co., LLC holds 5,526 shares of LLY stock, worth $4.02 Million. This represents 2.6% of its overall portfolio holdings.

Number of Shares
5,526
Previous 5,502 0.44%
Holding current value
$4.02 Million
Previous $4.98 Million 1.73%
% of portfolio
2.6%
Previous 2.78%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $18,531 - $23,040
24 Added 0.44%
5,526 $4.9 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $152,947 - $191,807
211 Added 3.99%
5,502 $4.98 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $15,397 - $20,599
-26 Reduced 0.49%
5,291 $4.12 Million
Q4 2023

Jan 30, 2024

SELL
$525.19 - $619.13 $292,005 - $344,236
-556 Reduced 9.47%
5,317 $3.1 Million
Q3 2023

Nov 03, 2023

SELL
$434.7 - $599.3 $8,694 - $11,986
-20 Reduced 0.34%
5,873 $3.15 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $47,267 - $55,076
-147 Reduced 2.43%
5,893 $2.16 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $32,053 - $37,636
115 Added 1.94%
6,040 $1.96 Million
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $78,151 - $97,122
-333 Reduced 5.32%
5,925 $1.7 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $73,750 - $91,525
-328 Reduced 4.98%
6,258 $1.73 Million
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $2,216 - $2,727
-10 Reduced 0.15%
6,586 $1.52 Million
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $13,541 - $17,515
-75 Reduced 1.12%
6,596 $1.51 Million
Q1 2021

Apr 13, 2021

SELL
$164.32 - $212.72 $10,187 - $13,188
-62 Reduced 0.92%
6,671 $1.25 Million
Q2 2020

Jul 29, 2020

SELL
$136.42 - $164.18 $25,510 - $30,701
-187 Reduced 2.7%
6,733 $1.11 Million
Q1 2020

Jul 28, 2020

SELL
$119.05 - $147.35 $65,001 - $80,453
-546 Reduced 7.31%
6,920 $960,000
Q4 2019

Jul 28, 2020

BUY
$106.92 - $132.43 $798,264 - $988,722
7,466 New
7,466 $981,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Carl P. Sherr & Co., LLC Portfolio

Follow Carl P. Sherr & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.